PROFILPELAJAR.COM

Hidroxokobalamina

Hidroxokobalamina
Formula kimikoaC62H89CoN13O15P
SMILES kanonikoa[O-)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[OH-].[Co+3]&zoom=2.0&annotate=none 2D eredua]
SMILES isomerikoa
[OH-].[Co+3].C[C@H](CNC(=O)CC[C@]1(C)[C@@H](CC(N)=O)[C@H]2[N-]C1=C(C)C3=NC(=CC4=NC(=C(C)C5=N[C@]2(C)[C@@](C)(CC(N)=O)[C@@H]5CCC(N)=O)[C@@](C)(CC(N)=O)[C@@H]4CCC(N)=O)C(C)(C)[C@@H]3CCC(N)=O)OP([O-])(=O)O[C@@H]6[C@@H](CO)O[C@@H]([C@@H]6O)N7C=NC8=C7C=C(C)C(C)=C8
MolView[O-)OC(C)CNC(=O)CCC4(C(C5C6(C(C(C(=N6)C(=C7C(C(C(=N7)C=C8C(C(C(=N8)C(=C4[N-]5)C)CCC(=O)N)(C)C)CCC(=O)N)(C)CC(=O)N)C)CCC(=O)N)(C)CC(=O)N)C)CC(=O)N)C)O.[OH-].[Co+3] 3D eredua]
Konposizioakobalto eta karbono
Motakonposatu heterozikliko
Masa molekularra1.345,567065778 Da eta 1.345,567065778 Da
Erabilera
Konposatu aktiboaCyanokit (en) Itzuli
Tratatzen duesklerosi anizkoitz, alcoholic neuropathy (en) Itzuli, diabetic polyneuropathy (en) Itzuli eta anemia kaltegarri
Rolahematinic (en) Itzuli, B taldearen bitaminak eta WHO farmako esentzial
Identifikatzaileak
InChlKeyYOZNUFWCRFCGIH-WZHZPDAFSA-K
CAS zenbakia13422-51-0
ChemSpider21160115
PubChem44475014 eta 163191904
Gmelin27786
ChEBI5723
ChEMBLCHEMBL2103737
EC zenbakia236-533-2
ECHA100.033.198
MeSHD006879
RxNorm5514
Human Metabolome DatabaseHMDB0002308
UNIIQ40X8H422O
NDF-RTN0000146311
KEGGD01027
Ohar medikoa
Ohar medikoa
Oharra: Wikipediak ez du mediku aholkurik ematen. Tratamendua behar duzula uste baduzu, jo ezazu sendagilearengana.

Hidroxokobalamina, B12a bitamina bezala ere ezaguna, elikagaietan aurkitzen den bitamina bat da, bere sintesi bakterianoan elikadura-osagarri bezala erabiltzen dutena.[1] Osagarri bezala, B12 bitaminaren eskasia tratatzeko erabiltzen dute, anemia perniziosoa barne.[1]

Hidroxokobalamina 1949an patentatu zuten.[2]

Erreferentziak

  1. ↑ a b (Ingelesez) WHO Model Formulary 2008. World Health Organization, 251 or. ISBN 9789241547659..
  2. ↑ (Ingelesez) Fischer, Janos; Ganellin, C. Robin. (2006). Analogue-based Drug Discovery. John Wiley & Sons, 489 or. ISBN 9783527607495..

Kanpo estekak


Kimika Artikulu hau kimikari buruzko zirriborroa da. Wikipedia lagun dezakezu edukia osatuz.

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.